| scholarly article | Q13442814 |
| P2093 | author name string | Fei Wang | |
| Nan Li | |||
| Zhi Yang | |||
| Keneng Chen | |||
| Luyan Shen | |||
| Shaohua Ma | |||
| P2860 | cites work | The role of positron emission tomography in management of small cell lung cancer | Q37869608 |
| Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis | Q37885139 | ||
| Role of positron emission tomography computed tomography in carcinoma lung evaluation | Q37902444 | ||
| Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer | Q37909663 | ||
| Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. | Q43144742 | ||
| Early prediction of response to first-line therapy using integrated 18F-FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer. | Q45986978 | ||
| Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy | Q46882519 | ||
| Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. | Q46972942 | ||
| Non-small cell lung carcinoma: accuracy of PET/CT in determining the size of T1 and T2 primary tumors | Q47380042 | ||
| Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan. | Q53206111 | ||
| Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer. | Q53222694 | ||
| Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial. | Q53254546 | ||
| Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial | Q84132797 | ||
| PET-CT in the staging and treatment of non-small-cell lung cancer | Q84379472 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | Chinese | Q7850 |
| P921 | main subject | Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 |
| P304 | page(s) | 21-26 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Chinese Journal of Lung Cancer | Q26842043 |
| P1476 | title | [Application of ¹⁸F-FDG PET/CT in pulmonary disease: a report of 419 cases]. | |
| P478 | volume | 15 |
| Q24187743 | PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer | cites work | P2860 |
Search more.